Background: The literature on antipsychotic medication in psychosis lack systematization of the empirical knowledge base on patients’ subjective experiences of using antipsychotic drugs. Such investigations are pivotal to inform large-scale trials with clinically relevant hypotheses and to illuminate clinical implications for different sub-groups of individuals. Aims: To re-analyze and summarize existing qualitative research literature on patient perspectives of using antipsychotic medication. Method: A systematic literature search was performed in September 2018 (Protocol registration no. CRD42017074394). Using an existing framework of meta-analyzing qualitative research, full text evaluation was conducted for 41 articles. Thirty-two art...
Background: The evidence on factors that may influence treatment decisional capacity (‘capacity) in ...
Objective: The primary purpose of this article is to review the treatment for schizophrenia with ant...
<p>INTRODUCTION: The prevalence of schizophrenia is thought to be about one in 100; about 75% ...
Background: The literature on antipsychotic medication in psychosis lack systematization of the empi...
Background: The literature on antipsychotic medication in psychosis lack systematization of the empi...
Background: The literature on antipsychotic medication in psychosis lack systematization of the empi...
Background: The literature on antipsychotic medication in psychosis lack systematization of the empi...
Background: The literature on antipsychotic medication in psychosis lack systematization of the empi...
Background: The literature on antipsychotic medication in psychosis lack systematization of the empi...
Background: Schizophrenia is generally considered a chronic disorder characterized by psychotic symp...
Background: For treatment of patients diagnosed with schizophrenia, comparative long-term effectiven...
Objective: To gain a better understanding of how long-acting injectable antipsychotic (LAI) therapy ...
BACKGROUND: Government policy encourages increasing involvement of patients in their long-term care....
CONTEXT AND OBJECTIVE: According to some cohort studies, the prevalence of refractory schizophrenia ...
Objective: Our aim in this article is 2-fold: first, to examine the mid-term to long-term data on ef...
Background: The evidence on factors that may influence treatment decisional capacity (‘capacity) in ...
Objective: The primary purpose of this article is to review the treatment for schizophrenia with ant...
<p>INTRODUCTION: The prevalence of schizophrenia is thought to be about one in 100; about 75% ...
Background: The literature on antipsychotic medication in psychosis lack systematization of the empi...
Background: The literature on antipsychotic medication in psychosis lack systematization of the empi...
Background: The literature on antipsychotic medication in psychosis lack systematization of the empi...
Background: The literature on antipsychotic medication in psychosis lack systematization of the empi...
Background: The literature on antipsychotic medication in psychosis lack systematization of the empi...
Background: The literature on antipsychotic medication in psychosis lack systematization of the empi...
Background: Schizophrenia is generally considered a chronic disorder characterized by psychotic symp...
Background: For treatment of patients diagnosed with schizophrenia, comparative long-term effectiven...
Objective: To gain a better understanding of how long-acting injectable antipsychotic (LAI) therapy ...
BACKGROUND: Government policy encourages increasing involvement of patients in their long-term care....
CONTEXT AND OBJECTIVE: According to some cohort studies, the prevalence of refractory schizophrenia ...
Objective: Our aim in this article is 2-fold: first, to examine the mid-term to long-term data on ef...
Background: The evidence on factors that may influence treatment decisional capacity (‘capacity) in ...
Objective: The primary purpose of this article is to review the treatment for schizophrenia with ant...
<p>INTRODUCTION: The prevalence of schizophrenia is thought to be about one in 100; about 75% ...